Form 8-K - Current report:
SEC Accession No. 0001437749-23-017339
Filing Date
2023-06-14
Accepted
2023-06-14 06:02:27
Documents
13
Period of Report
2023-06-09
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K qtntq20230605_8k.htm   iXBRL 8-K 33833
  Complete submission text file 0001437749-23-017339.txt   155211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA noticker-20230609.xsd EX-101.SCH 3634
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20230609_def.xml EX-101.DEF 10426
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20230609_lab.xml EX-101.LAB 13859
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20230609_pre.xml EX-101.PRE 10417
7 EXTRACTED XBRL INSTANCE DOCUMENT qtntq20230605_8k_htm.xml XML 2307
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

EIN.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 231012936
SIC: 2835 In Vitro & In Vivo Diagnostic Substances